Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Huot

Showing results (11-20 of 107) with videos related to

Pageof 11
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|March 11, 2018
Predictive Value of Parkinsonian Primates in Pharmacologic Studies: A Comparison between the Macaque, Marmoset, and Squirrel MonkeyNicolas Veyres, Adjia Hamadjida, Philippe Huot
Neurodegenerative Disease Management|May 4, 2023
5-HT<sub>1A</sub> agonists for levodopa-induced dyskinesia in Parkinson's diseaseJawad Al-Kassmy, Christine Sun, Philippe Huot
Clinical Neuropharmacology|March 29, 2020
Effect of Antidepressants on Psychotic Symptoms in Parkinson Disease: A Review of Case Reports and Case SeriesLamia Sid-Otmane, Philippe Huot, Michel Panisset
The Journal of Pharmacology and Experimental Therapeutics|May 19, 2016
Dopamine Reuptake Inhibitors in Parkinson's Disease: A Review of Nonhuman Primate Studies and Clinical TrialsPhilippe Huot, Susan H Fox, Jonathan M Brotchie
Progress in Neurobiology|September 1, 2011
The serotonergic system in Parkinson's diseasePhilippe Huot, Susan H Fox, Jonathan M Brotchie
Parkinson'S Disease|March 27, 2015
Monoamine reuptake inhibitors in Parkinson's diseasePhilippe Huot, Susan H Fox, Jonathan M Brotchie
Behavioural Pharmacology|September 15, 2018
Classic animal models of Parkinson's disease: a historical perspectiveAdjia Hamadjida, Imane Frouni, Cynthia Kwan, et al.
Pharmacological Reports : PR|June 27, 2022
Evaluation of the effects of the mGlu<sub>2/3</sub> antagonist LY341495 on dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmosetStephen G Nuara, Jim C Gourdon, Philippe Huot
Progress in Brain Research|March 6, 2022
Cognition and serotonin in Parkinson's diseaseImane Frouni, Cynthia Kwan, Sébastien Belliveau, et al.
The Neurologist|January 22, 2024
Anticonvulsant Agents for Treatment of Restless Legs Syndrome: A Case Report With Lamotrigine and a Review of the LiteratureJawad Al-Kassmy, Mohammed Alsalmi, Woojin Kang, et al.
Pageof 11

Showing results (11-20 of 107) with videos related to

Sort By:
Pageof 11
The Journal of Pharmacology and Experimental Therapeutics|March 11, 2018
Predictive Value of Parkinsonian Primates in Pharmacologic Studies: A Comparison between the Macaque, Marmoset, and Squirrel MonkeyNicolas Veyres, Adjia Hamadjida, Philippe Huot
Neurodegenerative Disease Management|May 4, 2023
5-HT<sub>1A</sub> agonists for levodopa-induced dyskinesia in Parkinson's diseaseJawad Al-Kassmy, Christine Sun, Philippe Huot
Clinical Neuropharmacology|March 29, 2020
Effect of Antidepressants on Psychotic Symptoms in Parkinson Disease: A Review of Case Reports and Case SeriesLamia Sid-Otmane, Philippe Huot, Michel Panisset
The Journal of Pharmacology and Experimental Therapeutics|May 19, 2016
Dopamine Reuptake Inhibitors in Parkinson's Disease: A Review of Nonhuman Primate Studies and Clinical TrialsPhilippe Huot, Susan H Fox, Jonathan M Brotchie
Progress in Neurobiology|September 1, 2011
The serotonergic system in Parkinson's diseasePhilippe Huot, Susan H Fox, Jonathan M Brotchie
Parkinson'S Disease|March 27, 2015
Monoamine reuptake inhibitors in Parkinson's diseasePhilippe Huot, Susan H Fox, Jonathan M Brotchie
Behavioural Pharmacology|September 15, 2018
Classic animal models of Parkinson's disease: a historical perspectiveAdjia Hamadjida, Imane Frouni, Cynthia Kwan, et al.
Pharmacological Reports : PR|June 27, 2022
Evaluation of the effects of the mGlu<sub>2/3</sub> antagonist LY341495 on dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmosetStephen G Nuara, Jim C Gourdon, Philippe Huot
Progress in Brain Research|March 6, 2022
Cognition and serotonin in Parkinson's diseaseImane Frouni, Cynthia Kwan, Sébastien Belliveau, et al.
The Neurologist|January 22, 2024
Anticonvulsant Agents for Treatment of Restless Legs Syndrome: A Case Report With Lamotrigine and a Review of the LiteratureJawad Al-Kassmy, Mohammed Alsalmi, Woojin Kang, et al.
Pageof 11